MedTrace Logo

Skin Cell Regeneration Efficacy of Cosmetic Product

NCT07096466 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-07-31

No results posted yet for this study

Summary

The objective of the study is to investigate the effect of one cosmetic product (exfoliator) containing Mitopure on the skin cell regeneration as well as on the skin hydration and skin barrier function in comparison to an untreated control area on the volar forearms.

Conditions

  • Healthy Skin

Interventions

OTHER

DHA stain

On day 1, the volar forearm test area will undergo DHA staining (250μl of 10% DHA solution applied under occlusion with Finn Chambers for 8 hours)

OTHER

No DHA stain

On day 1, the volar forearm test area will not undergo DHA staining.

OTHER

Cosmetic product application - forearm

The cosmetic product will be applied twice daily for two weeks to the volar forearm test area.

OTHER

No cosmetic product application - forearm

The cosmetic product will not be applied for two weeks to the volar forearm test area.

OTHER

Cosmetic products application - face

For two weeks on the face (excluding eye area), a cleansing cosmetic product containing Mitopure will be applied twice daily, and the cosmetic test product (that is used on forearms) will be applied once daily.

Sponsors & Collaborators

  • SGS proderm GmbH

    collaborator UNKNOWN

  • Amazentis SA

    lead INDUSTRY

Principal Investigators

  • Dr Katrin Unbereit · SGS proderm GmbH

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-06-23
Primary Completion
2025-07-09
Completion
2025-07-09

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07096466 on ClinicalTrials.gov